Literature DB >> 26564718

Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver.

Christoph Eckert1, Yong Ook Kim2, Henrike Julich1, Eva-Carina Heier1, Niklas Klein1, Elmar Krause3, Thomas Tschernig4, Miroslaw Kornek1, Frank Lammert1, Detlef Schuppan2, Veronika Lukacs-Kornek5.   

Abstract

Podoplanin/gp38(+) stromal cells present in lymphoid organs play a central role in the formation and reorganization of the extracellular matrix and in the functional regulation of immune responses. Gp38(+) cells are present during embryogenesis and in human livers of primary biliary cirrhosis. Since little is known about their function, we studied gp38(+) cells during chronic liver inflammation in models of biliary and parenchymal liver fibrosis and steatohepatitis. Gp38(+) cells were analyzed using flow cytometry and confocal microscopy, and the expression of their steady state and inflammation-associated genes was evaluated from healthy and inflamed livers. Gp38(+) cells significantly expanded in all three models of liver injury and returned to baseline levels during regression of inflammation. Based on CD133 and gp38 expression in the CD45(-)CD31(-)Asgpr1(-) liver cell fraction, numerous subsets could be identified that were negative for CD133 (gp38(hi)CD133(-), gp38(low)CD133(-), and gp38(-)CD133(-)). Moreover, among the CD133(+) cells, previously identified as progenitor population in injured liver, two subpopulations could be distinguished based on their gp38 expression (gp38(-)CD133(+) and CD133(+)gp38(+)). Importantly, the distribution of the identified subsets in inflammation illustrated injury-specific changes. Moreover, the gp38(+)CD133(+) cells exhibited liver progenitor cell characteristics similar to the gp38(-)CD133(+) population, thus representing a novel subset within the classical progenitor cell niche. Additionally, these cells expressed distinct sets of inflammatory genes during liver injury. Our study illuminates a novel classification of the stromal/progenitor cell compartment in the liver and pinpoints a hitherto unrecognized injury-related alteration in progenitor subset composition in chronic liver inflammation and fibrosis.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  NASH; fibrosis; inflammation; oval cells

Mesh:

Substances:

Year:  2015        PMID: 26564718      PMCID: PMC4698439          DOI: 10.1152/ajpgi.00344.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  50 in total

Review 1.  Update on the pathophysiology of liver fibrosis.

Authors:  Massimo Pinzani; Jose Macias-Barragan
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 3.869

Review 2.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 3.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

4.  Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation.

Authors:  Ruo-Lang Pan; Ping Wang; Li-Xin Xiang; Jian-Zhong Shao
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

5.  Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice.

Authors:  Michele T Pritchard; Laura E Nagy
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 6.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

Review 7.  The quest for liver progenitor cells: a practical point of view.

Authors:  Laurent Dollé; Jan Best; Jie Mei; Feras Al Battah; Hendrik Reynaert; Leo A van Grunsven; Albert Geerts
Journal:  J Hepatol       Date:  2009-10-28       Impact factor: 25.083

8.  Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.

Authors:  Yury Popov; Deanna Y Sverdlov; Anisha K Sharma; K Ramakrishnan Bhaskar; Shaoyong Li; Tobias L Freitag; James Lee; Walburga Dieterich; Gerry Melino; Detlef Schuppan
Journal:  Gastroenterology       Date:  2011-01-26       Impact factor: 22.682

9.  A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers.

Authors:  Sayuri Konishi; Kentaro Yasuchika; Takamichi Ishii; Ken Fukumitsu; Naoko Kamo; Naoya Fujita; Iwao Ikai; Shinji Uemoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-20       Impact factor: 2.416

10.  Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans.

Authors:  Alexander Link; Debbie L Hardie; Stéphanie Favre; Mirjam R Britschgi; David H Adams; Michael Sixt; Jason G Cyster; Christopher D Buckley; Sanjiv A Luther
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

View more
  10 in total

1.  Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination.

Authors:  Henrike Julich-Haertel; Marina Tiwari; Christina Mehrfeld; Elmar Krause; Miroslaw Kornek; Veronika Lukacs-Kornek
Journal:  J Vis Exp       Date:  2017-02-18       Impact factor: 1.355

2.  Monocyte upregulation of podoplanin during early sepsis induces complement inhibitor release to protect liver function.

Authors:  Zhanli Xie; Bojing Shao; Christopher Hoover; Michael McDaniel; Jianhua Song; Miao Jiang; Zhenni Ma; Fei Yang; Jingjing Han; Xia Bai; Changgeng Ruan; Lijun Xia
Journal:  JCI Insight       Date:  2020-07-09

Review 3.  The diversity and plasticity of adult hepatic progenitor cells and their niche.

Authors:  Jiamei Chen; Long Chen; Mark A Zern; Neil D Theise; Ann Mae Diehl; Ping Liu; Yuyou Duan
Journal:  Liver Int       Date:  2017-02-23       Impact factor: 5.828

4.  Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.

Authors:  Maria Cimini; Antonio Cannatá; Gianandrea Pasquinelli; Marcello Rota; Polina Goichberg
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

Review 5.  Podoplanin in Inflammation and Cancer.

Authors:  Miguel Quintanilla; Lucía Montero-Montero; Jaime Renart; Ester Martín-Villar
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

6.  Identification and Isolation of Cardiac Fibroblasts From the Adult Mouse Heart Using Two-Color Flow Cytometry.

Authors:  Mara Stellato; Marcin Czepiel; Oliver Distler; Przemysław Błyszczuk; Gabriela Kania
Journal:  Front Cardiovasc Med       Date:  2019-08-01

Review 7.  Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?

Authors:  Artur Słomka; Bingduo Wang; Tudor Mocan; Adelina Horhat; Arnulf G Willms; Ingo G H Schmidt-Wolf; Christian P Strassburg; Maria A Gonzalez-Carmona; Veronika Lukacs-Kornek; Miroslaw T Kornek
Journal:  Theranostics       Date:  2022-08-01       Impact factor: 11.600

Review 8.  The Role of Lymphatic Endothelial Cells in Liver Injury and Tumor Development.

Authors:  Veronika Lukacs-Kornek
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

9.  Ex Vivo Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Are a Heterogeneous Population That Demonstrate Rapid Culture-Induced Changes.

Authors:  Anna E S Brooks; Megan Iminitoff; Eloise Williams; Tanvi Damani; Victoria Jackson-Patel; Vicky Fan; Joanna James; P Rod Dunbar; Vaughan Feisst; Hilary M Sheppard
Journal:  Front Pharmacol       Date:  2020-02-20       Impact factor: 5.810

Review 10.  Immune Aging and How It Works for Inflammation and Fibrosis.

Authors:  Hiroshi Nishiura; Mai Imasaka; Koji Yamanegi; Jiro Fujimoto; Masaki Ohmuraya
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.